Trinitrophenol

Trinitrophenol

SCHEMBL7529527

O=[N+]([O-])c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1.[LiH]

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TRPA1TRPV4

The experimentally established mechanism targets of Trinitrophenol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR35 Q9HC97 11/20 0.76
▸ ALDH1A1 P00352 4/20 0.76
▸ HPGD P15428 2/20 0.76
▸ MAPK1 P28482 2/20 0.76
▸ MEN1 O00255 2/20 0.76
▸ KMT2A Q03164 2/20 0.76
▸ KDM4E B2RXH2 1/20 0.76
▸ TTR P02766 1/20 0.76
▸ CYP1A2 P05177 1/20 0.76
▸ MAPT P10636 1/20 0.76
▸ CYP2C9 P11712 1/20 0.76
▸ ALOX15 P16050 1/20 0.76
▸ ALOX12 P18054 1/20 0.76
▸ RECQL P46063 1/20 0.76
▸ PMP22 Q01453 1/20 0.76
▸ HIF1A Q16665 1/20 0.76
▸ HSD17B10 Q99714 1/20 0.76
▸ TDP1 Q9NUW8 1/20 0.76
▸ TP53 P04637 1/20 0.57
▸ TSHR P16473 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trinitrophenol SCHEMBL253750 0.98 GPR35 (0.79) GPR35ALDH1A1HPGDMAPK1MEN1
Trinitrophenol SCHEMBL8744 0.98 GPR35 (0.79) GPR35ALDH1A1HPGDMAPK1MEN1
Trinitrophenol SCHEMBL223710 0.95 GPR35 (0.76) GPR35ALDH1A1HPGDMAPK1MEN1
Trinitrophenol SCHEMBL7514072 0.95 GPR35 (0.76) GPR35ALDH1A1HPGDMAPK1MEN1
Trinitrophenol SCHEMBL10361561 0.95 GPR35 (0.76) GPR35ALDH1A1HPGDMAPK1MEN1
Trinitrophenol SCHEMBL2260895 0.95 GPR35 (0.76) GPR35ALDH1A1HPGDMAPK1MEN1
Trinitrophenol SCHEMBL7514069 0.95 GPR35 (0.76) GPR35ALDH1A1HPGDMAPK1MEN1
Trinitrophenol SCHEMBL7161632 0.95 GPR35 (0.76) GPR35ALDH1A1HPGDMAPK1MEN1
Trinitrophenol SCHEMBL11029133 0.95 GPR35 (0.76) GPR35ALDH1A1HPGDMAPK1MEN1
Trinitrophenol SCHEMBL5908860 0.95 GPR35 (0.76) GPR35ALDH1A1HPGDMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-8105899-A — — None — — JP disclosed
CN-101443399-A Stabilizer composition for halogenated polymers with improved initial color and improved color retention BAERLOCHER GMBH (DE) 2009-05-27 — — CN disclosed
CN-101248129-A Stabilizer composition based on nitrogen compounds for stabilizing halogenated polymers BAERLOCHER GMBH (DE) 2008-08-20 — — CN disclosed
US-20020155443-A1 Metal binding DNA interactive compounds BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2002-10-24 — — US disclosed
EP-0703453-B1 Method for the determination of creatinine and urinary protein BAYER AG (US) 2001-11-07 — — EP disclosed
EP-0703453-A1 Dry reagent for creatinine assay Bayer Corporation (US) 1996-03-27 — — EP disclosed
US-5464777-A Dry reagent for creatinine assay MILES INC. (US) 1995-11-07 — — US disclosed
US-4668397-A CYCLODIMERIZATION, TETRAPEPTIDES AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JP) 1987-05-26 — — US disclosed
EP-0153370-A1 A METHOD FOR PREPARATION OF A UNITARY DRY REAGENT SYSTEM CONTAINING HETEROGENEOUS CHEMICALS AMERICAN HOSPITAL SUPPLY CORPORATION (US) 1985-09-04 — — EP disclosed
WO-1985001107-A1 A METHOD FOR PREPARATION OF A UNITARY DRY REAGENT SYSTEM CONTAINING HETEROGENEOUS CHEMICALS AMERICAN HOSPITAL SUPPLY CORPORATION (US) 1985-03-14 — — WO disclosed
US-4147545-A FOR DIAZO-SENSITIZED PHOTOSENSITIVE COATINGS POLYCHROME CORPORATION (US) 1979-04-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020155443-A1 Metal binding DNA interactive compounds DNMT1, DNMT3A, DNMT3B GPR35 4442/4885ALDH1A1 2457/4885HPGD 3229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback